Efficacy and safety in key patient subgroups of nivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naïve patien...

Date 28 September 2015
Event European Cancer Congress 2015
Session Melanoma and Skin Cancer II
Topics Melanoma and other Skin Tumours
Presenter Larkin, J.